Alterations in Serum BDNF and GDNF Levels after 12 Weeks of Antidepressant Treatment in Female Outpatients with Major Depressive Disorder
| Autor: | Bun-Hee Lee, Young-Min Park |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2018 |
| Předmět: |
medicine.medical_specialty
Remission animal diseases behavioral disciplines and activities Brain-derived neurotrophic factor Glial cell line-derived neurotrophic factor 03 medical and health sciences 0302 clinical medicine Neurotrophic factors Internal medicine mental disorders Medicine Major depression Biological Psychiatry Depression (differential diagnoses) biology business.industry urogenital system medicine.disease 030227 psychiatry Psychiatry and Mental health Moderate depression Endocrinology nervous system biology.protein Major depressive disorder Antidepressant Original Article business 030217 neurology & neurosurgery After treatment |
| Zdroj: | Psychiatry Investigation |
| ISSN: | 1976-3026 1738-3684 |
| Popis: | Objective Some clinical studies have found alterations in the levels of serum brain-derived neurotrophic factor (BDNF) and glial cell line-derived neurotrophic factor (GDNF) after applying antidepressant treatment in patients with major depressive disorder (MDD). We evaluated the serum BDNF and GDNF levels before and after 12 weeks of antidepressant treatment in MDD outpatients. Methods Serum BDNF and GDNF levels were measured in 23 female MDD outpatients at baseline and after 12 weeks of treatment. The severity of depression was measured with the Hamilton Depression Rating Scale-17 (HAMD-17). Remission of MDD to the treatment was defined as a posttreatment HAMD-17 score of l7. Results Among MDD patients, 19 (82.6%) subjects were in mild to moderate depression. The whole MDD patients had significantly higher serum BDNF and GDNF levels at baseline than those after 12 weeks of antidepressant treatment. The baseline serum BDNF and GDNF levels did not significantly between the remission and nonremission groups. The significant alteration in both BDNF and GDNF levels after antidepressant treatment were observed in patients with remission. Conclusion The present study suggests that the baseline serum BDNF and GDNF levels are higher than the posttreatment levels in some mild-to-moderate MDD outpatients and the significant alteration in BDNF and GDNF level after treatment were observed in patients with remission. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|